WHO ICTRP trial
Hitting the Mark: Introducing state-of-the-art MRI for precision radiotherapy of…
NL-OMON55947 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON55947 |
|---|---|
| Public title | Hitting the Mark: Introducing state-of-the-art MRI for precision radiotherapy of glioblastoma |
| Scientific title | Hitting the Mark: Introducing state-of-the-art MRI for precision radiotherapy of glioblastoma - MOSAIC |
| Primary sponsor | Erasmus MC, Universitair Medisch Centrum Rotterdam |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational non invasive |
| Countries | Netherlands |
| Conditions | brain tumor glioblastoma;10029211 |
| Registration date | Jul 28, 2023 |
| Target size | 53 |
| Secondary IDs | NL84994.078.23 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: